CARDIOVASCULAR
Encorium has performed over 130 cardiovascular studies involving over 40,000 patients at 3,100 international sites. Our expertise ranges from preclinical studies including molecular pharmacology and receptor analysis, phase I PK/PD trials, thorough QT/QTc evaluations through pivotal phase III studies, and patient disease registries. We have worked with over 35 clients in the field of cardiovascular research and have helped design and conduct multiple landmark studies in atherosclerosis, hypertension, heart failure, hyperlipidemia and endothelial dysfunction.
Encorium have a network of more than 3,000 specialty and general practice physicians with clinical trial experience in this therapeutic area and have long standing relationships with many of the world’s leading cardiologists.
Encorium provide valuable consulting to clients on clinical and operational challenges associated with cardiovascular drug development.
Cardiovascular Indications
Click on the area of interest for further breakdown of the experience Encorium has.
+ Ischemic Heart Disease
+ Hypertension
+ Heart Failure (HF)
+ Cardiovascular Risk Factors
+ Endothelial Dysfunction
+ Arrhythmias
+ Thorough QT/QTc Evaluation
+ Carotid Artery Disease
+ Renal Disease
+ Erectile Dysfunction
+ Cardiopulmonary Disease
+ Anticoagulation Therapy
+ Hemostasis
+ Medical Imaging in Cardiovascular Trials
+ Oversight Committees in Cardiovascular Disease
+ Oversight of Core Laboratories
|
